From the Safety Data Sheet posted earlier
So what does
From the Safety Data Sheet posted earlier
So what does it really cost to use Bril ?
Dosing uses 65ml per Kg in females and 75ml per Kg for males as a general guide line.
Taking 8ug/ml in upper dosing in their example and using a 100kg male 75ml * 100Kg = 7500ml
7500ml * 8ug = .06 or 60mg
This is intended as general reference for understanding the amount usedand it's attendant cost. I used the SDS article and is not intended in any shape form or format to be used as a clinical reference.
I am after a general reference of the cost per patient per dose.
Using 60 mg for a 100kg male and the cost per 10 mg of Brilacidin is $980 US therefore 6 X $980 =$5880 dollars. Obviously, if you wanted to sponsor a test and needed kg of the material the cost would come down dramatically around 99%.
If you had a disease or knew of a person that had a disease that there was no cure for most of us would throw $10,000 on the table in a heartbeat to help a fellow human being.
I just wanted to know what the bottom line cost was as I had never calculated it.
In many lab test with test cells containing a viral growth medium they were using concentrations on the order of 50~100ug / ml.
Where Brilacidin excels is it's ability as a defensin protein as it will strip the outer membrane in bacteria and Alpha viruses, thus leaving bacteria or viruses extremely vulnerable to the immune system and in many cases leaving the pathogen unable to obtain entry to the host cell. Believe it or not many of the foods we eat everyday will dock to the main protease in most viruses. Once the outer protective layer is removed from viruses and bacteria common foods we eat everyday contain organic molecules that will dock to the main protease in the virus, thus inhibiting the virus.
The immune system will easily disassemble the virus or bacteria at this point and create antibodies.
Cheers
6
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
Top 5 Most Recently Viewed Articles
AbbVie Unveils Positive Outcomes for Epcoritamab in DLBCL AbbVie, in collaboration with Genmab, has revealed exciting topline results from the pivotal Phase 3 EPCORE DLBCL-1 trial investigating the efficacy of Epcoritamab, a bispecific T-cell engaging antibody administered subcutaneously. This groundbreaking study targets adults with relapsed or refractory diffuse large...
Continue Reading
Introduction to Varonis Systems, Inc. Varonis Systems, Inc. is recognized for its innovative data security solutions that enable businesses to safeguard sensitive information. However, recent developments have prompted a closer examination of the company's practices and disclosures regarding their financial performance and management strategies. Investor Concerns and...
Continue Reading
A U. S. District Court was gearing up to dig into a plea deal that had Boeing in hot water. The aerospace giant, known for its commercial jets, was facing backlash over its handling of the tragic Boeing 737 MAX crashes. Families of those lost weren’t just sitting idle; they were challenging the terms of this agreement like it was their only shot at justice. Boeing's...
Continue Reading
Introducing Bomberger's PFG™: A New Milestone in Bourbon Michter's Distillery has once again made waves in the world of whiskey with the debut of Bomberger's PFG™ (Precision Fine Grain) Kentucky Straight Bourbon. This innovative release captures the essence of traditional bourbon-making while raising the art of whiskey production to new heights. Michter's Master...
Continue Reading
Understanding the Leadership Crisis Amidst Change As workplaces evolve and become more distributed, an unseen challenge is taking root that could threaten the effectiveness of corporate leadership. Recent research has shed light on this pressing issue, revealing profound insights into leadership dynamics and the need for innovative solutions. A comprehensive study...
Continue Reading